Physician profile
Gouri Ramesh
NPI 1982634119
$510.22
in general payments reported to CMS, 2019-2025
11 companies · $72.27 in 2025
The $72.27 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.73 · 2020: $26.36 · 2021: $200 · 2022: $90.67 · 2023: $61.48 · 2024: $31.32 · 2025: $72.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $200.92 | 2020-2024 | Bexsero |
| Pfizer INC. | $75.18 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $60.60 | 2022-2023 | Austedo Xr |
| Stryker Corporation | $36.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi Pasteur INC. | $28.07 | 2019-2021 | |
| Modernatx, INC. | $24.06 | 2022 | |
| Merck Sharp & Dohme LLC | $18.16 | 2024 | Gardasil, Vaxelis, Gardasil 9 |
| Exact Sciences Corporation | $17.99 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $17.55 | 2025 | |
| Qiagen, LLC | $16.50 | 2019 | |
| Abbott Laboratories | $14.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gouri Ramesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.